TORONTO, April 5, 2018 /CNW/ - Syncordia Technologies and Healthcare Solutions, Corp. (TSXV: SYN) (the "Company")has been operating under a forbearance arrangement with its secured lender since July 2017. Efforts to sell the business or refinance have not succeeded. The Company has now received: (i) a demand letter for immediate repayment of its Secured Notes
The Company received the resignation of each of the Company's Directors dated today.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Syncordia Technologies and Healthcare Solutions, Corp.
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All